Novel Focal Therapy Yields Low Rate of Serious Prostate Cancers
The use of a novel focal therapy technique called high-frequency irreversible electroporation (H-FIRE) for the treatment of localized prostate cancer resulted in a 6-month clinically significant prostate cancer (csPCa) rate lower than previously seen with other energy platforms, according to Chinese investigators. Among the 100 patients who received H-FIRE and were biopsied at 6 months, […]